“Pharmaceutical Product Development” (USA) has purchased “InnPharma” (Russia), the largest Russian company specializing in clinical trials of new medicines. “InnPharma” carries out clinical trials in more than 300 Russian clinics.
American companies increase their presence on the Russian market of clinical trials of new medicines
